| Title | Prescribing Trends with Daptomycin (Cubicin) For the Treatment of Gram-Positive Infections. | | Author(s) | Chan Tompkins NH, Harnicar SJ | | Institution | Dr. Tompkins is a Clinical Specialist in Infectious Diseases at Allegheny General Hospital's Department of Pharmacy in Pittsburgh, Pennsylvania. At the time of this project, Dr. Harnicar was a Pharmacy Technician at Allegheny General Hospital. He is currently an Oncology Pharmacy Resident at Memorial Sloan-Kettering Cancer Center in New York, New York. | | Source | P T 2008 May; 33(5):282-288. | | Abstract | The injectable agent daptomycin, when prescribed according to approved guidelines, can be a welcome option for treating some multiresistant, gram-positive infections that have become increasingly prevalent. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19561791 |
|
